Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

Endoscopic transmission of carbapenem-resistant Enterobacteriaceae: implications for U.S. Food and Drug Administration approval and postmarket surveillance of endoscopic devices.

PMID: 32750323 ·

N, a, s, i, r, , S, a, l, e, e, m, ;, , M, o, h, a, m, m, a, d, , K, , I, s, m, a, i, l, ;, , C, l, a, u, d, i, o, , R, , T, o, m, b, a, z, z, i, ;, , S, a, r, t, h, a, k, , S, o, i, n, ;, , S, a, n, k, e, t, , S, , D, h, r, u, v, a

RevistaGastrointestinal endoscopy
Año
PMID32750323

Resumen

Since the first widely reported case cluster of duodenoscope-associated transmission of carbapenem-resistant Enterobacteriaceae (CRE) in 2013 that affected 38 patients, similar outbreaks have occurred throughout the world. The U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention, professional gastroenterology societies, and endoscope manufacturers have taken multiple steps to address this issue. Unlike prior outbreaks attributed to lapses in cleaning and reprocessi

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑